US FDA approves Sun's new drug to market Topamax

The shipment of the product to the US has commenced, Sun Pharma said in a statement.
These tablets are therapeutically equivalent to Topamax tablets from Ortho-McNeil Janssen Pharmaceuticals, the release said.
The tablets are available in 25 mg, 50 mg, 100 mg and 200 mg. Topamax tablets have annual sales of $2.5 billion in the US, Sun said.
Topiramate, an anticonvulsant, is indicated as initial monotherapy in patients of 10 years of age and older with partial onset or primary generalised tonic-clonic seizures.
It is indicated as adjunctive therapy for adults and paediatric patients with partial onset seizures or primary generalised tonic-clonic seizures, it said.
Topiramate, an anticonvulsant, is indicated as initial monotherapy in patients of 10 years of age and older with partial onset or primary generalised tonic-clonic seizures.
It is indicated as adjunctive therapy for adults and paediatric patients with partial onset seizures or primary generalised tonic-clonic seizures, it said.
Source : economictimes.indiatimes.com
Post a Comment